Anne Libby
Concepts (361)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medicaid | 12 | 2024 | 433 | 1.650 |
Why?
| Mental Health Services | 12 | 2016 | 404 | 1.590 |
Why?
| Financing, Organized | 4 | 2020 | 30 | 1.320 |
Why?
| Research Personnel | 5 | 2020 | 156 | 1.180 |
Why?
| Comparative Effectiveness Research | 4 | 2013 | 148 | 1.060 |
Why?
| Depressive Disorder, Major | 5 | 2009 | 345 | 0.930 |
Why?
| Indians, North American | 6 | 2008 | 600 | 0.900 |
Why?
| Nonprescription Drugs | 3 | 2016 | 66 | 0.880 |
Why?
| Substance-Related Disorders | 8 | 2008 | 1022 | 0.860 |
Why?
| Biomedical Research | 5 | 2020 | 638 | 0.850 |
Why?
| Antidepressive Agents | 6 | 2015 | 228 | 0.810 |
Why?
| Managed Care Programs | 10 | 2011 | 133 | 0.800 |
Why?
| Depressive Disorder | 6 | 2015 | 366 | 0.740 |
Why?
| Faculty, Medical | 4 | 2022 | 264 | 0.730 |
Why?
| Mentoring | 3 | 2022 | 131 | 0.730 |
Why?
| Sex Factors | 7 | 2022 | 1968 | 0.730 |
Why?
| Capitation Fee | 5 | 2002 | 14 | 0.680 |
Why?
| Interdisciplinary Research | 1 | 2020 | 26 | 0.670 |
Why?
| Mental Disorders | 5 | 2017 | 1030 | 0.670 |
Why?
| Sex Characteristics | 3 | 2022 | 737 | 0.620 |
Why?
| United States Food and Drug Administration | 4 | 2009 | 204 | 0.580 |
Why?
| Emergency Services, Psychiatric | 1 | 2017 | 31 | 0.560 |
Why?
| Pharmacists | 2 | 2024 | 247 | 0.560 |
Why?
| Child Welfare | 4 | 2007 | 211 | 0.550 |
Why?
| Academic Medical Centers | 3 | 2020 | 481 | 0.540 |
Why?
| Writing | 1 | 2018 | 91 | 0.530 |
Why?
| Interdisciplinary Studies | 1 | 2016 | 28 | 0.530 |
Why?
| Prescription Drugs | 2 | 2016 | 112 | 0.520 |
Why?
| Mentors | 5 | 2022 | 178 | 0.510 |
Why?
| Academies and Institutes | 1 | 2016 | 49 | 0.510 |
Why?
| Child Abuse | 6 | 2008 | 517 | 0.500 |
Why?
| Science | 1 | 2016 | 49 | 0.490 |
Why?
| Contract Services | 3 | 2002 | 10 | 0.480 |
Why?
| United States | 30 | 2024 | 13900 | 0.480 |
Why?
| Fee-for-Service Plans | 5 | 2002 | 88 | 0.470 |
Why?
| Health Policy | 5 | 2016 | 353 | 0.470 |
Why?
| Colorado | 17 | 2020 | 4420 | 0.460 |
Why?
| Quality-Adjusted Life Years | 3 | 2014 | 106 | 0.460 |
Why?
| Health Care Costs | 2 | 2010 | 367 | 0.450 |
Why?
| Child Abuse, Sexual | 3 | 2007 | 90 | 0.450 |
Why?
| Juvenile Delinquency | 3 | 2004 | 109 | 0.440 |
Why?
| Dibenzothiazepines | 1 | 2013 | 17 | 0.440 |
Why?
| Telemedicine | 2 | 2024 | 788 | 0.430 |
Why?
| Humans | 76 | 2024 | 129622 | 0.430 |
Why?
| Cooperative Behavior | 1 | 2016 | 431 | 0.420 |
Why?
| Data Collection | 5 | 2012 | 650 | 0.420 |
Why?
| Medication Therapy Management | 1 | 2014 | 72 | 0.420 |
Why?
| Length of Stay | 2 | 2017 | 1127 | 0.420 |
Why?
| Adolescent | 33 | 2017 | 20391 | 0.410 |
Why?
| Antihypertensive Agents | 3 | 2024 | 485 | 0.410 |
Why?
| Videoconferencing | 2 | 2017 | 64 | 0.400 |
Why?
| Cohort Studies | 13 | 2016 | 5420 | 0.400 |
Why?
| Suicide, Attempted | 3 | 2015 | 349 | 0.390 |
Why?
| Female | 49 | 2024 | 68770 | 0.390 |
Why?
| Physicians | 4 | 2022 | 864 | 0.380 |
Why?
| Cities | 1 | 2012 | 105 | 0.370 |
Why?
| Male | 46 | 2024 | 63674 | 0.370 |
Why?
| Income | 1 | 2012 | 189 | 0.370 |
Why?
| Antipsychotic Agents | 1 | 2013 | 195 | 0.370 |
Why?
| Unemployment | 1 | 2010 | 43 | 0.350 |
Why?
| Cost of Illness | 1 | 2012 | 278 | 0.340 |
Why?
| Plant Preparations | 1 | 2010 | 32 | 0.340 |
Why?
| Depression | 3 | 2014 | 1307 | 0.340 |
Why?
| Research Support as Topic | 3 | 2020 | 111 | 0.330 |
Why?
| Cost-Benefit Analysis | 6 | 2017 | 569 | 0.320 |
Why?
| Polypharmacy | 2 | 2024 | 84 | 0.320 |
Why?
| Prescriptions | 1 | 2009 | 66 | 0.310 |
Why?
| Tobacco Smoke Pollution | 1 | 2012 | 231 | 0.310 |
Why?
| Child, Preschool | 14 | 2017 | 10518 | 0.310 |
Why?
| Point-of-Care Systems | 1 | 2010 | 147 | 0.300 |
Why?
| Multivariate Analysis | 6 | 2017 | 1502 | 0.300 |
Why?
| Epilepsy | 1 | 2012 | 329 | 0.300 |
Why?
| Middle Aged | 28 | 2022 | 31150 | 0.300 |
Why?
| Child | 24 | 2017 | 20882 | 0.290 |
Why?
| Premature Birth | 1 | 2012 | 314 | 0.290 |
Why?
| Stress Disorders, Post-Traumatic | 2 | 2007 | 825 | 0.290 |
Why?
| Health Maintenance Organizations | 2 | 2005 | 97 | 0.290 |
Why?
| Cross-Sectional Studies | 8 | 2017 | 5066 | 0.290 |
Why?
| Health Services Accessibility | 3 | 2007 | 902 | 0.290 |
Why?
| Chronic Disease | 2 | 2013 | 1720 | 0.280 |
Why?
| Drug and Narcotic Control | 1 | 2007 | 28 | 0.270 |
Why?
| Combat Disorders | 1 | 2007 | 37 | 0.270 |
Why?
| Interview, Psychological | 1 | 2007 | 92 | 0.270 |
Why?
| Substance Withdrawal Syndrome | 1 | 2009 | 176 | 0.270 |
Why?
| Research Design | 3 | 2019 | 1043 | 0.270 |
Why?
| Parents | 3 | 2017 | 1309 | 0.260 |
Why?
| Education, Medical | 2 | 2020 | 243 | 0.260 |
Why?
| Longitudinal Studies | 8 | 2016 | 2716 | 0.260 |
Why?
| Health Behavior | 1 | 2012 | 741 | 0.260 |
Why?
| Decision Making | 1 | 2013 | 850 | 0.250 |
Why?
| Diabetes Mellitus | 2 | 2014 | 1001 | 0.250 |
Why?
| Adult | 25 | 2019 | 35572 | 0.250 |
Why?
| Hypoglycemia | 1 | 2010 | 427 | 0.240 |
Why?
| Aged, 80 and over | 9 | 2024 | 7084 | 0.240 |
Why?
| Aged | 19 | 2024 | 22099 | 0.240 |
Why?
| Rural Population | 2 | 2007 | 518 | 0.230 |
Why?
| Retrospective Studies | 12 | 2016 | 14519 | 0.230 |
Why?
| Ambulatory Care | 4 | 2014 | 504 | 0.230 |
Why?
| Stress, Psychological | 2 | 2010 | 1066 | 0.230 |
Why?
| Family | 2 | 2006 | 657 | 0.230 |
Why?
| Smoking | 1 | 2012 | 1501 | 0.230 |
Why?
| Curriculum | 3 | 2020 | 916 | 0.230 |
Why?
| Suicide | 3 | 2007 | 580 | 0.230 |
Why?
| Parenting | 1 | 2008 | 295 | 0.220 |
Why?
| Crime | 1 | 2004 | 57 | 0.220 |
Why?
| Practice Patterns, Physicians' | 4 | 2007 | 1266 | 0.220 |
Why?
| Deprescriptions | 1 | 2024 | 34 | 0.210 |
Why?
| Electronic Health Records | 3 | 2015 | 975 | 0.200 |
Why?
| Primary Health Care | 4 | 2024 | 1679 | 0.190 |
Why?
| Infant | 9 | 2017 | 9025 | 0.190 |
Why?
| Residential Treatment | 1 | 2002 | 30 | 0.190 |
Why?
| Brain Injuries | 2 | 2005 | 468 | 0.190 |
Why?
| Foster Home Care | 1 | 2003 | 79 | 0.190 |
Why?
| Adolescent Psychiatry | 1 | 2002 | 14 | 0.190 |
Why?
| Anxiety Disorders | 1 | 2005 | 356 | 0.190 |
Why?
| Logistic Models | 6 | 2017 | 1988 | 0.190 |
Why?
| Contracts | 1 | 2001 | 10 | 0.190 |
Why?
| Criminal Law | 1 | 2002 | 30 | 0.180 |
Why?
| Child Psychiatry | 1 | 2002 | 35 | 0.180 |
Why?
| Hypoglycemic Agents | 1 | 2010 | 1220 | 0.180 |
Why?
| Costs and Cost Analysis | 3 | 2010 | 201 | 0.180 |
Why?
| Schizophrenia | 1 | 2005 | 431 | 0.180 |
Why?
| Health Surveys | 3 | 2010 | 494 | 0.180 |
Why?
| Hospitals, Pediatric | 2 | 2017 | 509 | 0.180 |
Why?
| Severity of Illness Index | 6 | 2014 | 2742 | 0.180 |
Why?
| Surface Plasmon Resonance | 1 | 2021 | 88 | 0.180 |
Why?
| Dementia | 1 | 2024 | 227 | 0.170 |
Why?
| Caregivers | 3 | 2024 | 815 | 0.170 |
Why?
| Hypertension | 2 | 2022 | 1242 | 0.170 |
Why?
| Dried Blood Spot Testing | 1 | 2021 | 94 | 0.170 |
Why?
| Organizational Innovation | 2 | 2020 | 138 | 0.170 |
Why?
| Organophosphates | 1 | 2021 | 120 | 0.170 |
Why?
| Women's Health | 2 | 2020 | 365 | 0.170 |
Why?
| Young Adult | 10 | 2017 | 12426 | 0.170 |
Why?
| Education | 1 | 2020 | 101 | 0.160 |
Why?
| Population Groups | 3 | 2017 | 60 | 0.160 |
Why?
| Interdisciplinary Communication | 1 | 2020 | 186 | 0.160 |
Why?
| Adenine | 1 | 2021 | 256 | 0.150 |
Why?
| Suicidal Ideation | 2 | 2015 | 463 | 0.150 |
Why?
| Health Services Research | 3 | 2016 | 391 | 0.150 |
Why?
| Foundations | 1 | 2018 | 24 | 0.150 |
Why?
| Gender Identity | 1 | 2019 | 122 | 0.150 |
Why?
| Program Evaluation | 5 | 2021 | 875 | 0.140 |
Why?
| Hospitalization | 2 | 2011 | 2070 | 0.140 |
Why?
| Chi-Square Distribution | 3 | 2012 | 516 | 0.140 |
Why?
| Hospital Costs | 2 | 2012 | 114 | 0.140 |
Why?
| Sexism | 1 | 2018 | 55 | 0.140 |
Why?
| Program Development | 1 | 2019 | 357 | 0.140 |
Why?
| Attitude to Health | 2 | 2017 | 431 | 0.140 |
Why?
| Dose-Response Relationship, Drug | 2 | 2013 | 2012 | 0.140 |
Why?
| Leadership | 1 | 2020 | 354 | 0.130 |
Why?
| Public Health Administration | 1 | 1997 | 75 | 0.130 |
Why?
| Reminder Systems | 1 | 2017 | 174 | 0.120 |
Why?
| Risk Factors | 8 | 2012 | 9763 | 0.120 |
Why?
| Veterans | 1 | 2007 | 1398 | 0.120 |
Why?
| Immunization | 1 | 2017 | 411 | 0.120 |
Why?
| Alcoholism | 1 | 2002 | 766 | 0.120 |
Why?
| Comorbidity | 3 | 2015 | 1547 | 0.110 |
Why?
| Accidents | 2 | 2005 | 39 | 0.110 |
Why?
| Community Mental Health Services | 2 | 2007 | 89 | 0.110 |
Why?
| Quetiapine Fumarate | 1 | 2013 | 23 | 0.110 |
Why?
| Oregon | 1 | 2013 | 70 | 0.110 |
Why?
| Health Information Management | 1 | 2013 | 7 | 0.110 |
Why?
| Patient Satisfaction | 1 | 2017 | 633 | 0.100 |
Why?
| Decision Support Techniques | 2 | 2014 | 396 | 0.100 |
Why?
| Statistics, Nonparametric | 1 | 2014 | 422 | 0.100 |
Why?
| Interviews as Topic | 2 | 2020 | 717 | 0.100 |
Why?
| Alcohol-Related Disorders | 2 | 2005 | 118 | 0.100 |
Why?
| Health Expenditures | 2 | 2006 | 179 | 0.100 |
Why?
| Minority Groups | 2 | 2022 | 249 | 0.100 |
Why?
| Age Factors | 5 | 2012 | 3144 | 0.100 |
Why?
| Medical Audit | 1 | 2013 | 77 | 0.100 |
Why?
| Analysis of Variance | 2 | 2014 | 1288 | 0.100 |
Why?
| Regression Analysis | 3 | 2011 | 993 | 0.100 |
Why?
| Women's Health Services | 2 | 2006 | 16 | 0.100 |
Why?
| Medical Records Systems, Computerized | 1 | 2013 | 93 | 0.100 |
Why?
| Economics, Pharmaceutical | 1 | 2012 | 9 | 0.100 |
Why?
| Evidence-Based Medicine | 1 | 2016 | 718 | 0.100 |
Why?
| Education, Pharmacy, Graduate | 1 | 2012 | 17 | 0.100 |
Why?
| Pilot Projects | 2 | 2024 | 1587 | 0.100 |
Why?
| Prevalence | 3 | 2011 | 2564 | 0.100 |
Why?
| Efficiency | 1 | 2012 | 91 | 0.100 |
Why?
| Referral and Consultation | 1 | 2017 | 733 | 0.100 |
Why?
| Diagnostic Tests, Routine | 1 | 2013 | 102 | 0.100 |
Why?
| Education, Graduate | 1 | 2012 | 34 | 0.100 |
Why?
| Chemoembolization, Therapeutic | 1 | 2012 | 48 | 0.090 |
Why?
| Health Services | 1 | 2012 | 99 | 0.090 |
Why?
| Maternal Age | 1 | 2012 | 124 | 0.090 |
Why?
| Self Care | 1 | 2014 | 369 | 0.090 |
Why?
| Advisory Committees | 3 | 2007 | 216 | 0.090 |
Why?
| Patient-Centered Care | 1 | 2016 | 505 | 0.090 |
Why?
| Hospitals, University | 1 | 2012 | 179 | 0.090 |
Why?
| Nausea | 1 | 2011 | 110 | 0.090 |
Why?
| Infant, Small for Gestational Age | 1 | 2012 | 85 | 0.090 |
Why?
| Psychomotor Agitation | 1 | 2011 | 64 | 0.090 |
Why?
| State Health Plans | 2 | 2002 | 32 | 0.090 |
Why?
| Radiography, Interventional | 1 | 2012 | 105 | 0.090 |
Why?
| Interinstitutional Relations | 1 | 2011 | 54 | 0.090 |
Why?
| Sexual Dysfunction, Physiological | 1 | 2011 | 67 | 0.090 |
Why?
| Insurance, Health, Reimbursement | 1 | 2012 | 94 | 0.090 |
Why?
| Vomiting | 1 | 2011 | 128 | 0.090 |
Why?
| Employment | 1 | 2012 | 167 | 0.090 |
Why?
| Medicare | 3 | 2024 | 720 | 0.090 |
Why?
| Policy Making | 1 | 2011 | 88 | 0.090 |
Why?
| Drug Labeling | 2 | 2007 | 41 | 0.090 |
Why?
| Headache | 1 | 2011 | 151 | 0.090 |
Why?
| Social Support | 2 | 2020 | 588 | 0.090 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2011 | 100 | 0.090 |
Why?
| Computer Communication Networks | 1 | 2010 | 32 | 0.090 |
Why?
| Heart Transplantation | 1 | 2016 | 721 | 0.080 |
Why?
| Medication Adherence | 1 | 2014 | 558 | 0.080 |
Why?
| Proportional Hazards Models | 3 | 2015 | 1201 | 0.080 |
Why?
| Influenza, Human | 2 | 2017 | 601 | 0.080 |
Why?
| Life Style | 1 | 2012 | 460 | 0.080 |
Why?
| California | 3 | 2007 | 401 | 0.080 |
Why?
| Carcinoma, Hepatocellular | 1 | 2012 | 272 | 0.080 |
Why?
| Drug Utilization Review | 1 | 2009 | 57 | 0.080 |
Why?
| Vaccination | 1 | 2017 | 1348 | 0.080 |
Why?
| Residence Characteristics | 1 | 2012 | 328 | 0.080 |
Why?
| Information Dissemination | 1 | 2011 | 205 | 0.080 |
Why?
| Financing, Government | 2 | 2000 | 43 | 0.080 |
Why?
| Surveys and Questionnaires | 4 | 2020 | 5401 | 0.080 |
Why?
| Community-Institutional Relations | 1 | 2009 | 95 | 0.070 |
Why?
| Drug Prescriptions | 2 | 2007 | 248 | 0.070 |
Why?
| HIV Infections | 2 | 2021 | 2720 | 0.070 |
Why?
| Catheter Ablation | 1 | 2012 | 335 | 0.070 |
Why?
| Prospective Studies | 3 | 2021 | 7131 | 0.070 |
Why?
| Absorptiometry, Photon | 1 | 2009 | 248 | 0.070 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2007 | 43 | 0.070 |
Why?
| Office Visits | 1 | 2007 | 85 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2009 | 769 | 0.070 |
Why?
| Databases, Factual | 4 | 2016 | 1269 | 0.070 |
Why?
| Trauma Severity Indices | 2 | 2005 | 104 | 0.070 |
Why?
| Liver Neoplasms | 1 | 2012 | 640 | 0.070 |
Why?
| Infant, Newborn | 4 | 2012 | 5762 | 0.070 |
Why?
| Drug Utilization | 1 | 2007 | 171 | 0.060 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 236 | 0.060 |
Why?
| Sleep | 1 | 2011 | 685 | 0.060 |
Why?
| Diagnosis, Dual (Psychiatry) | 1 | 2005 | 36 | 0.060 |
Why?
| Physicians, Family | 1 | 2007 | 207 | 0.060 |
Why?
| Alcohol Drinking | 1 | 2012 | 764 | 0.060 |
Why?
| Cost Savings | 2 | 2012 | 78 | 0.060 |
Why?
| Parent-Child Relations | 1 | 2008 | 256 | 0.060 |
Why?
| Bone Density | 1 | 2009 | 471 | 0.060 |
Why?
| Pregnancy | 2 | 2020 | 6402 | 0.060 |
Why?
| Psychiatry | 1 | 2007 | 179 | 0.060 |
Why?
| Northwestern United States | 1 | 2004 | 55 | 0.060 |
Why?
| Southwestern United States | 1 | 2004 | 91 | 0.050 |
Why?
| Florida | 1 | 2024 | 93 | 0.050 |
Why?
| Age of Onset | 1 | 2005 | 496 | 0.050 |
Why?
| Brain Damage, Chronic | 1 | 2003 | 20 | 0.050 |
Why?
| Direct Service Costs | 1 | 2003 | 10 | 0.050 |
Why?
| Volition | 1 | 2003 | 30 | 0.050 |
Why?
| Quality of Life | 1 | 2015 | 2704 | 0.050 |
Why?
| Treatment Outcome | 3 | 2013 | 10226 | 0.050 |
Why?
| Odds Ratio | 2 | 2004 | 1023 | 0.050 |
Why?
| Tobacco Use Disorder | 1 | 2005 | 237 | 0.050 |
Why?
| Monte Carlo Method | 2 | 2014 | 143 | 0.050 |
Why?
| Sampling Studies | 1 | 2003 | 96 | 0.050 |
Why?
| Somatoform Disorders | 1 | 2003 | 42 | 0.050 |
Why?
| Physician-Patient Relations | 1 | 2007 | 537 | 0.050 |
Why?
| Marijuana Abuse | 1 | 2005 | 234 | 0.050 |
Why?
| Rehabilitation, Vocational | 1 | 2002 | 2 | 0.050 |
Why?
| Angiotensin Receptor Antagonists | 1 | 2022 | 89 | 0.050 |
Why?
| Cost Allocation | 1 | 2002 | 7 | 0.050 |
Why?
| Qualitative Research | 2 | 2020 | 1234 | 0.050 |
Why?
| Factor Analysis, Statistical | 1 | 2003 | 284 | 0.050 |
Why?
| Calcium Channel Blockers | 1 | 2022 | 161 | 0.050 |
Why?
| Child Health Services | 2 | 2001 | 185 | 0.050 |
Why?
| Case-Control Studies | 1 | 2009 | 3381 | 0.050 |
Why?
| Reimbursement, Incentive | 1 | 2002 | 36 | 0.050 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 198 | 0.050 |
Why?
| Emergency Medical Services | 1 | 2007 | 522 | 0.050 |
Why?
| Immunity | 1 | 2022 | 139 | 0.050 |
Why?
| Data Interpretation, Statistical | 1 | 2003 | 335 | 0.050 |
Why?
| Confidence Intervals | 1 | 2002 | 317 | 0.040 |
Why?
| Practice Management, Medical | 1 | 2001 | 36 | 0.040 |
Why?
| Adrenergic beta-Antagonists | 1 | 2022 | 321 | 0.040 |
Why?
| Adolescent Behavior | 1 | 2005 | 506 | 0.040 |
Why?
| Occupational Diseases | 1 | 2002 | 138 | 0.040 |
Why?
| Feasibility Studies | 1 | 2024 | 867 | 0.040 |
Why?
| International Classification of Diseases | 2 | 2015 | 122 | 0.040 |
Why?
| Incidence | 2 | 2005 | 2644 | 0.040 |
Why?
| Pediatrics | 1 | 2007 | 1052 | 0.040 |
Why?
| Models, Statistical | 1 | 2003 | 623 | 0.040 |
Why?
| Carcinoma, Ductal, Breast | 1 | 1999 | 82 | 0.040 |
Why?
| Social Stigma | 1 | 2020 | 117 | 0.040 |
Why?
| Risk Assessment | 3 | 2015 | 3240 | 0.040 |
Why?
| Health Care Surveys | 2 | 1997 | 559 | 0.040 |
Why?
| Career Choice | 1 | 2019 | 207 | 0.040 |
Why?
| Competitive Bidding | 1 | 1997 | 3 | 0.030 |
Why?
| Decision Making, Organizational | 1 | 1997 | 26 | 0.030 |
Why?
| Administrative Personnel | 1 | 1997 | 29 | 0.030 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3628 | 0.030 |
Why?
| Blood Pressure | 1 | 2024 | 1735 | 0.030 |
Why?
| Motivation | 1 | 2001 | 546 | 0.030 |
Why?
| Pneumococcal Infections | 1 | 2017 | 110 | 0.030 |
Why?
| Specialization | 2 | 2007 | 145 | 0.030 |
Why?
| Pneumococcal Vaccines | 1 | 2017 | 140 | 0.030 |
Why?
| National Institute of Mental Health (U.S.) | 1 | 2016 | 4 | 0.030 |
Why?
| Models, Organizational | 1 | 1997 | 145 | 0.030 |
Why?
| Citalopram | 1 | 2015 | 30 | 0.030 |
Why?
| Medicine | 2 | 2007 | 118 | 0.030 |
Why?
| Immunization Programs | 1 | 2017 | 214 | 0.030 |
Why?
| Fluoxetine | 1 | 2015 | 53 | 0.030 |
Why?
| Focus Groups | 1 | 2017 | 453 | 0.030 |
Why?
| Clinical Protocols | 1 | 2016 | 255 | 0.030 |
Why?
| Treatment Failure | 1 | 2015 | 340 | 0.030 |
Why?
| Uncertainty | 1 | 2014 | 116 | 0.030 |
Why?
| Urban Population | 1 | 1997 | 441 | 0.030 |
Why?
| Reoperation | 1 | 2016 | 545 | 0.030 |
Why?
| Probability | 1 | 2014 | 306 | 0.030 |
Why?
| American Recovery and Reinvestment Act | 1 | 2013 | 6 | 0.030 |
Why?
| Insurance Claim Review | 1 | 2013 | 64 | 0.030 |
Why?
| Influenza Vaccines | 1 | 2017 | 532 | 0.020 |
Why?
| Drug Therapy, Combination | 1 | 2015 | 1040 | 0.020 |
Why?
| Adenocarcinoma | 1 | 1999 | 898 | 0.020 |
Why?
| Linear Models | 1 | 2014 | 819 | 0.020 |
Why?
| Diabetes Complications | 1 | 2014 | 224 | 0.020 |
Why?
| Schools, Pharmacy | 1 | 2012 | 46 | 0.020 |
Why?
| Databases as Topic | 1 | 2011 | 59 | 0.020 |
Why?
| Decision Trees | 1 | 2012 | 90 | 0.020 |
Why?
| Models, Economic | 1 | 2012 | 53 | 0.020 |
Why?
| Radiotherapy | 1 | 2012 | 188 | 0.020 |
Why?
| Faculty | 1 | 2012 | 137 | 0.020 |
Why?
| Health Care Rationing | 1 | 2011 | 57 | 0.020 |
Why?
| Propensity Score | 1 | 2011 | 265 | 0.020 |
Why?
| Patient Discharge | 1 | 2016 | 857 | 0.020 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 146 | 0.020 |
Why?
| Legislation, Medical | 1 | 2007 | 11 | 0.020 |
Why?
| Poverty Areas | 1 | 2007 | 35 | 0.020 |
Why?
| Crisis Intervention | 1 | 2007 | 33 | 0.020 |
Why?
| Computer Simulation | 1 | 2012 | 943 | 0.020 |
Why?
| Appointments and Schedules | 1 | 2007 | 84 | 0.020 |
Why?
| Breast Neoplasms | 1 | 1999 | 2142 | 0.020 |
Why?
| Students | 1 | 2012 | 580 | 0.020 |
Why?
| Least-Squares Analysis | 1 | 2006 | 78 | 0.020 |
Why?
| Ontario | 1 | 2006 | 90 | 0.020 |
Why?
| Drug Monitoring | 1 | 2007 | 216 | 0.020 |
Why?
| Osteoporosis | 1 | 2009 | 232 | 0.020 |
Why?
| Time Factors | 1 | 2016 | 6556 | 0.020 |
Why?
| Health Status Indicators | 1 | 2006 | 167 | 0.020 |
Why?
| Seasons | 1 | 2007 | 502 | 0.010 |
Why?
| Pandemics | 1 | 2011 | 1486 | 0.010 |
Why?
| Physician Incentive Plans | 1 | 2000 | 6 | 0.010 |
Why?
| Cost Control | 1 | 2000 | 39 | 0.010 |
Why?
| Multicenter Studies as Topic | 1 | 2002 | 286 | 0.010 |
Why?
| Hospital Mortality | 1 | 2005 | 850 | 0.010 |
Why?
| Adolescent Health Services | 1 | 2001 | 76 | 0.010 |
Why?
| Workplace | 1 | 2002 | 246 | 0.010 |
Why?
| Health Care Reform | 1 | 2000 | 101 | 0.010 |
Why?
| Primary Prevention | 1 | 2000 | 188 | 0.010 |
Why?
| Interpersonal Relations | 1 | 2002 | 392 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2007 | 4896 | 0.010 |
Why?
| Adenocarcinoma, Mucinous | 1 | 1999 | 75 | 0.010 |
Why?
| Lymphatic Metastasis | 1 | 1999 | 320 | 0.010 |
Why?
| Quality Indicators, Health Care | 1 | 2000 | 298 | 0.010 |
Why?
| Disease-Free Survival | 1 | 1999 | 648 | 0.010 |
Why?
| Patient Care Team | 1 | 2002 | 605 | 0.010 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2002 | 1367 | 0.010 |
Why?
| Prognosis | 1 | 1999 | 3794 | 0.010 |
Why?
|
|
Libby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|